Samar R Saleh, Mariam M Abady, Mohammed Nofal, Nashwa W Yassa, Mohamed S Abdel-Latif, Mohamed Ismail Nounou, Doaa A Ghareeb, Nihad Abdel-Monaem
BACKGROUND: Berberine (BBR), an isoquinoline alkaloid, acts as a multipotent active pharmaceutical ingredient to counteract several types of dementia based on its numerous pharmacological actions including antioxidant, antiinflammatory, cholesterol-lowering effect, and inhibition of Aβ production and AChE. However, BBR suffers from poor absorption, bioavailability and brain drug uptake. The present study is directed for the formulation and characterization of Chitosan BBR-nanoparticles (BBR-NPs) as well as the estimation of its neuroprotective effects against scopolamine induced cognitive impairments...
June 28, 2020: Current Clinical Pharmacology